Bill Gross warns on gold momentum as regional bank stocks tumble
DUBLIN - Investment giant BlackRock, Inc. has disclosed a 1.62% stake in Mural Oncology plc, according to a regulatory filing published Thursday.
The filing, submitted to comply with Irish Takeover Panel rules, reveals that BlackRock holds 281,388 shares in the oncology-focused company as of September 3, 2025. This position includes 281,373 owned or controlled relevant securities and 15 shares through cash-settled derivatives.
The disclosure was made under Rule 8.3 of the Irish Takeover Panel Act, which requires persons with interests in relevant securities representing 1% or more to disclose their holdings.
Recent transactions disclosed in the filing include the return of 5,700 shares on loan and the transfer in of 858 shares. No short positions in Mural Oncology were reported by BlackRock.
The filing does not indicate any indemnity arrangements, options, or agreements related to voting rights of the securities.
The disclosure comes as part of standard regulatory requirements for significant shareholders during takeover situations, though the filing does not specify details about any ongoing offer involving Mural Oncology.
Based on the press release statement, BlackRock’s position was reported through the Regulatory Information Service of the London Stock Exchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.